Skip to main content
DongKookPharmaceuticalCo.,Ltd. logo

DongKookPharmaceuticalCo.,Ltd. — Investor Relations & Filings

Ticker · 086450 ISIN · KR7086450004 KO Manufacturing
Open in API
Filings indexed 159 across all filing types
Latest filing 2024-04-11 Director's Dealing
Country KR South Korea
Listing KO 086450

About DongKookPharmaceuticalCo.,Ltd.

https://www.dkpharm.co.kr/en/

DongKook Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of medical products. Established in 1968, the company focuses on improving human health and quality of life. Its product portfolio includes prescription and non-prescription drugs, with key therapeutic areas in anesthetics, contrast media, anti-cancer agents, antibiotics, and oral healthcare treatments. The company operates its own Active Pharmaceutical Ingredient (API) synthesis facilities and invests in research and development to create innovative therapeutic solutions. It provides both finished products and raw materials to domestic and international markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the share ownership changes of a specific executive (Oh Heung-ju) of Dongkook Pharmaceutical. This type of filing is a standard regulatory disclosure for insider transactions, which falls under the 'Director's Dealing' category.
2024-04-11 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed with the Financial Supervisory Service of South Korea. It details the specific number of shares disposed of, the price, the date of disposal, and the remaining treasury share balance. This falls under the category of a company reporting the sale or disposal of its own shares, which is classified as 'Transaction in Own Shares' (POS).
2024-04-05 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This document details the company's plan to sell or distribute its own shares, which falls under the category of 'Transaction in Own Shares' (POS).
2024-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend resolutions, and the election of directors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-22 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the shareholding status of Fidelity Management & Research Company LLC in Dongkuk Pharmaceutical Co., Ltd. This type of filing is a regulatory requirement for entities that cross specific ownership thresholds in a public company, which falls under the 'Major Shareholding Notification' category.
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Dongkook Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, financial highlights (assets, liabilities, revenue, profit), and auditor information. While it contains financial data, it is a standard regulatory announcement notifying the market that the audit report has been submitted to the regulator, rather than the full annual report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2023
2024-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.